NSGC Headquarters
Key Takeaways
- Research presented at the NSGC 45th Annual Conference explored how genetic counselors contribute to prenatal and cancer care and help patients understand genetic test results.
- New research identified disparities in who receives preferred prenatal genetic screening and examined how genetic testing may inform cancer care.
- Studies found that different types of genetic and tumor testing can provide information relevant to cancer treatment, while inherited genetic testing was recommended more often when genetic counselors participated in tumor board discussions.
- Patients reported less anxiety and uncertainty after receiving and discussing hereditary cancer genetic test results with a genetic counselor, including many patients whose results remained uncertain, according to new research from the conference.
New Research on Prenatal Screening and Cancer Care
Researchers at the National Society of Genetic Counselors (NSGC) 45th Annual Conference in Baltimore presented new findings on prenatal genetic screening, cancer testing and the experiences of patients receiving genetic test results.
Four studies examined differences in access to prenatal screening, the information available through comprehensive cancer testing, how genetic counselors contribute to cancer care teams and what patients report after discussing their test results.
Differences in Who Receives Preferred Prenatal Genetic Screening
Prenatal genetic screening helps assess the chance that a fetus has certain chromosomal conditions, including Down syndrome. Professional guidelines recommend offering prenatal screening to all pregnant patients, with cell-free DNA (cfDNA) screening preferred over traditional serum screening for pregnancies involving one fetus.
In a national study of 451,194 pregnant patients from 2018 to 2024, researchers found that 31.7% received cfDNA screening, compared with 68.2% who received traditional serum screening.
The study also found differences in who received cfDNA screening. Black patients were 13% less likely to receive the test than white patients, while patients whose preferred language was not English were 12% less likely to receive it than those who preferred English. Patients living in more socially disadvantaged or rural communities were also less likely to receive cfDNA screening.
The researchers did not examine the causes of these differences. The findings identify disparities in the use of a screening test that is more accurate at detecting common chromosomal conditions and can provide results earlier in pregnancy.
Genetic counselors can help obstetric providers stay current on screening recommendations and support efforts to expand access to genetic services, particularly in underserved communities.
Comprehensive Testing Identifies Potential Treatment Clues for Ovarian Cancer
Genetic and tumor testing can provide information that may help guide cancer treatment decisions. Different tests examine inherited genetic changes or characteristics of a tumor, and each can provide different information.
Researchers examined records from 1,053 patients with ovarian, fallopian tube or primary peritoneal cancer who completed four complementary types of genetic and tumor testing.
Among these patients, 96% had at least one finding with potential treatment implications. More than half (57%) had at least one positive result relevant to recommended treatment, while 41% had tumor findings associated with potential eligibility for a clinical trial.
The testing included screening for inherited genetic changes, such as those involving BRCA1 or BRCA2, and tumor characteristics that may help determine eligibility for certain targeted treatments.
Because different healthcare providers may order these tests separately, genetic counselors can help coordinate testing and interpret results so patients and their care teams understand the findings, potential implications, and how they can inform treatment plans.
More Genetic Testing Recommended When Counselors Participate in Cancer Tumor Boards
Tumor boards bring cancer specialists together to review patient cases and discuss treatment options. New research examined how recommendations for inherited genetic testing differed when a genetic counselor participated in these meetings.
Researchers reviewed 524 patient cases discussed at Maine Cancer Genomic Initiative tumor boards between June 2019 and June 2023, including cases discussed before and after a genetic counselor joined the meetings.
When a genetic counselor was present, inherited genetic testing was recommended in 36.5% of cases, compared with 9.8% of cases discussed without a genetic counselor.
The reasons for recommending testing differed as well. Without a genetic counselor, nearly three-quarters of recommendations were prompted by tumor testing results. When a genetic counselor participated, personal medical history was the most common reason for recommending testing.
Genetic counselors consider factors such as a patient's age at diagnosis, personal and family history, and current testing guidelines when assessing whether inherited genetic testing may be appropriate.
Results from inherited genetic testing can sometimes help guide cancer treatment and screening decisions. They may also provide information about cancer risks for family members.
Patients Report Less Anxiety and Uncertainty After Discussing Genetic Test Results
Genetic testing for hereditary cancer risk does not always provide a clear answer. Some patients receive a variant of uncertain significance (VUS), meaning researchers do not yet have enough information to determine whether a genetic change increases disease risk.
A study of 81 patients undergoing hereditary breast and ovarian cancer testing examined changes in anxiety and uncertainty before patients learned their genetic test results and after they received and discussed those results with a genetic counselor.
After the results appointments, patients' survey scores indicated 47% less uncertainty and nearly 28% less anxiety. Both changes were statistically significant.
The reduction in uncertainty also occurred among many patients who received inconclusive results. Of the 13 patients who received a VUS result, 11 reported feeling less uncertain after their appointment.
During results appointments, genetic counselors explain what findings mean for a patient's cancer risk and possible next steps, including additional screening or referrals. They can also discuss whether relatives may want to consider genetic testing.
What This Means for You
These studies address several situations in which patients and families may have questions about genetic testing.
If you are pregnant, you can ask your healthcare provider about available prenatal screening options and which tests are recommended for your pregnancy. If you have been diagnosed with cancer, you can ask whether inherited genetic testing or tumor testing may provide information relevant to your care.
Genetic counselors can help patients understand testing recommendations, interpret their results and discuss what those findings may mean for their health and family members.
Find Guidance and Support
If you have questions about genetic testing or your results, visit Find a Genetic Counselor to connect with a certified professional in your area or through telehealth.
This article is for educational purposes only and is not a substitute for medical advice. If you have questions about your genetic health or testing options, talk with your healthcare provider or a certified genetic counselor
Back to Resources 